Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented ThinkLabs AI on the transaction. ThinkLabs AI, a startup focused on developing technology to help enhance grid planning,...
ThinkLabs AI’s $5 Million Seed Financing Round
Travelers’ $435 Million Acquisition of Corvus Insurance
Skadden provided legal counsel to The Travelers Companies, Inc., while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian provided legal counsel to Corvus in the transaction. The...
Evident Vascular’s $35 Million Series A Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Evident Vascular in the transaction. Evident Vascular announced it has launched its $35 million Series A financing led by Vensana...
Alimera Sciences’ Acquisition of U.S. Commercial Rights to YUTIQ®
Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc. Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has...
Our Next Energy’s $300 Million Series B Financing
Gunderson Dettmer represented Our Next Energy (ONE) on the deal. Vinson & Elkins advised affiliates of Riverstone Holdings LLC. Our Next Energy (ONE), an energy storage...
Parallel Bio’s $4.3 Million Seed Funding
Gunderson Dettmer advised Parallel Bio on the deal. Parallel Bio, a biotechnology company, announced its $4.3 million seed round led by Refactor Capital. Parallel Bio created a...
Bevi’s $70 Million Series D Financing
Gunderson Dettmer represented Bevi on the deal. Bevi, the market leader in smart water coolers, announced its $70 million Series D financing from sustainability-focused investment platform, Cowen Sustainable...
GoCardless’ Acquisition of Nordigen
Sorainen advised Nordigen on the deal, while GoCardless was advised by Ellex and Fenwick. Nordigen, a freemium open banking data provider from Latvia, in a transaction...
Well’s $70 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Well on the deal. Well, a digital health improvement platform, announced its $70 million Series B financing led by...
Theseus Pharmaceuticals’ $160 Million IPO
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...